Literature DB >> 7578651

Buprenorphine for human immunovirus-positive opiate-dependent patients.

I D Montoya, A Umbricht, K L Preston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7578651      PMCID： PMC2633647          DOI： 10.1016/0006-3223(95)00071-N

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  6 in total

1.  Treatment of heroin addicts using buprenorphine.

Authors:  T R Kosten; C Morgan; H D Kleber
Journal:  Am J Drug Alcohol Abuse       Date:  1991-06       Impact factor: 3.829

2.  A controlled trial of buprenorphine treatment for opioid dependence.

Authors:  R E Johnson; J H Jaffe; P J Fudala
Journal:  JAMA       Date:  1992-05-27       Impact factor: 56.272

3.  Treatment of cocaine abuse with buprenorphine.

Authors:  T R Kosten; H D Kleber; C Morgan
Journal:  Biol Psychiatry       Date:  1989-10       Impact factor: 13.382

Review 4.  Buprenorphine.

Authors:  J W Lewis
Journal:  Drug Alcohol Depend       Date:  1985-02       Impact factor: 4.492

5.  Sublingual versus subcutaneous buprenorphine in opiate abusers.

Authors:  D R Jasinski; P J Fudala; R E Johnson
Journal:  Clin Pharmacol Ther       Date:  1989-05       Impact factor: 6.875

6.  Buprenorphine suppresses cocaine self-administration by rhesus monkeys.

Authors:  N K Mello; J H Mendelson; M P Bree; S E Lukas
Journal:  Science       Date:  1989-08-25       Impact factor: 47.728
  6 in total
  1 in total

1.  Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.

Authors:  Ivan D Montoya; David A Gorelick; Kenzie L Preston; Jennifer R Schroeder; Annie Umbricht; Lawrence J Cheskin; W Robert Lange; Carlo Contoreggi; Rolley E Johnson; Paul J Fudala
Journal:  Clin Pharmacol Ther       Date:  2004-01       Impact factor: 6.875
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.